Abdelali Majdi reflects on WCLC24 and Team Bayer’s contributions

Abdelali (Ali) Majdi posted the following on LinkedIn:

“Leaving San Diego after a memorable WCLC24.

So proud of our Team Bayer for the remarkable work sharing our science and engaging with the lung cancer community to imagine the future together.

Inspired by the active presence of patients and patient representatives in every conversation. Certainly one of the most patient-centric WCLC editions, from the opening to the closing plenary. Special thanks to Amy C. Moore, Yvonne Diaz, Anne-Marie Baird, Shani Shilo, Marcia Horn, and Jill Feldman.

Pleased to represent Team Bayer, founder and gold partner of the IASLC Partners for Thoracic Cancer Care. Insightful results from the 2024 Global Survey on Biomarker Testing in Lung Cancer were shared during the conference.

Impressed by the scientific research supported by the Lung Cancer Research Foundation and excited to see the LCRF | Bayer Research Grant officially announced.

Inspired by the conscious effort from IASLC to drive diversity, equity, and inclusion, and proud of our Team Bayer support to the IASLC symposium exploring challenges, opportunities and efforts to address inequalities in thoracic oncology.

Again, congratulations to the conference co-chairs Sandip Patel, M.D. Narjust Florez M.D. Dr. Fabio Ynoe de Moraes and Linda W Martin, MD, MPH, and the International Association for the Study of Lung Cancer leadership and amazing staff.

Team Bayer will be with you at WCLC25 Jarushka Naidoo Umberto Malapelle Isabelle Schmitt-Opitz Noemi Reguart, MD, PhD.”

Source: Abdelali (Ali) Majdi/LinkedIn